Scope of this summary
Adults with suspected or confirmed lower-extremity deep-vein thrombosis or acute pulmonary embolism. The ASH treatment source addresses people without cancer; pregnancy, active cancer, pediatrics, unusual-site thrombosis, heparin-induced thrombocytopenia and severe kidney or liver disease require the matching specialist source.
The Bottom Line
- Use validated clinical probability and objective testing to confirm VTE; do not diagnose or exclude DVT or PE from symptoms alone.
- For acute PE, apply the 2026 AHA/ACC A-to-E clinical categories to combine symptoms, severity scores, biomarkers, right-ventricular findings and cardiopulmonary failure.
- Asymptomatic category A PE can be discharged from the emergency department, and early discharge is generally recommended for category B when a safe outpatient system is in place; categories C through E should be hospitalized.
- When oral anticoagulation is suitable, the 2026 PE guideline recommends a direct oral anticoagulant over a vitamin-K antagonist unless contraindicated; ASH similarly favors DOACs for most eligible DVT/PE patients without cancer.
- After PE, assess symptoms and functional limitation at each visit for at least one year to detect chronic thromboembolic pulmonary disease or another cause of persistent dyspnea.
Practical clinical workflow
1
Assess stability first, then combine a validated pretest-probability approach with D-dimer or the appropriate compression-ultrasound or pulmonary vascular imaging pathway.
2
For confirmed PE, assign the current AHA/ACC clinical category and document right-ventricular findings, biomarkers, bleeding risk, comorbidity and social suitability for outpatient care.
3
Choose anticoagulant, setting and initial route from diagnosis, clinical category, kidney and liver function, pregnancy, cancer, interactions, adherence and cost.
4
Identify whether a major reversible risk factor, persistent risk factor or no major reversible factor is present and plan the primary and extended treatment phases accordingly.
5
Arrange early safety review, adherence and bleeding assessment, and PE-specific follow-up for recurrence, dyspnea and functional recovery.
Safety boundaries and escalation
- Persistent hypotension, incipient cardiopulmonary failure, severe hypoxemia, syncope or rapidly worsening right-heart strain requires hospital escalation and expert PE response; advanced reperfusion therapies are not routine outpatient care.
- Verify active bleeding, platelet count when relevant, kidney and liver function, pregnancy, interactions, weight and procedural plans before anticoagulation.
- Do not use a low severity score alone to discharge someone without reliable access to medicine, follow-up, emergency return and social support.
- New bleeding, recurrent chest pain or dyspnea, unilateral swelling, neurologic symptoms or hemodynamic change during treatment needs urgent reassessment.
Localization
US disposition uses the 2026 AHA/ACC PE categories and local emergency, PERT and outpatient infrastructure. Apply current FDA labeling and payer coverage, and use separate ASH guidance for cancer, pregnancy and other special populations.
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- American College of Cardiology and American Heart Association Joint Committee on Clinical Practice Guidelines2026 Guideline for the Evaluation and Management of Acute Pulmonary Embolism in AdultsDOI 10.1161/CIR.0000000000001415 路 published 2026-02-19 路 accessed 2026-08-20view source
- American Society of HematologyAmerican Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolismReviewed by ASH expert work group in 2022 and retained with annual evidence monitoring; page checked 2026-08-20 路 published 2020-10-02 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.